AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig

Read more

Lilly Announces Strategic Collaboration with KeyBioscience

Read more

Valeant Announces Sale of iNova Pharmaceuticals for $930 Million

Read more

Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy

Read more

Veloxis Announces Agreement with Chiesi to Commercialize Envarsus XR in China

Read more

Novartis drug Tasigna receives EU approval for inclusion of TFR data in product label

Read more

NIH researchers find potential genetic cause of Cushing syndrome

Read more

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology

Read more

Sanofi and Regeneron Present Positive Study Results for Investigational PD-1 Antibody REGN2810

Read more

Braeburn Pharmaceuticals appoints Michael M. Derkacz as President and CEO

Read more